| Enhancer ID: | E_01_0110 |
| Species: | human |
| Position : | chr1:153659104-153661104 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Antiviral |
| Pubmed ID: | 31878072 |
| Enhancer experiment: | RT qPCR, Western blot, CO immunoprecipitation, immunofluorescence |
| Enhancer experiment description: | Therefore, we present a distinct mechanism by which EV71 antagonizes ILF2-mediated antiviral effects by inhibiting ILF2 expression and promoting ILF2 translocation from the nucleus to the cytoplasm through its 2B protein. |
| Target gene : | ILF2 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Therefore, we present a distinct mechanism by which EV71 antagonizes ILF2-mediated antiviral effects by inhibiting ILF2 expression and promoting ILF2 translocation from the nucleus to the cytoplasm through its 2B protein. |
| TF name : | -- |
| TF experiment: | RT-qPCR?Western blot??????????? |
| TF experiment description: | Therefore, we present a distinct mechanism by which EV71 antagonizes ILF2-mediated antiviral effects by inhibiting ILF2 expression and promoting ILF2 translocation from the nucleus to the cytoplasm through its 2B protein. |
| Enhancer function : | Therefore, we present a distinct mechanism by which EV71 antagonizes ILF2-mediated antiviral effects by inhibiting ILF2 expression and promoting ILF2 translocation from the nucleus to the cytoplasm through its 2B protein. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Therefore, we present a distinct mechanism by which EV71 antagonizes ILF2-mediated antiviral effects by inhibiting ILF2 expression and promoting ILF2 translocation from the nucleus to the cytoplasm through its 2B protein. |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|